KRAS-话题@MedSci

#KRAS#

77篇内容 | 4156人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1369003, encodeId=a7a913690036c, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=ARCH PATHOL LAB MED：肺癌，结直肠癌和胰腺癌组织和血浆中KRAS突变检测的方法, objectType=article, longId=159572, objectId=4fbc1595e2df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fbc1595e2df, replyNumber=0, likeNumber=52, createdTime=2019-02-08, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fbc1595e2df, moduleTitle=ARCH PATHOL LAB MED：肺癌，结直肠癌和胰腺癌组织和血浆中KRAS突变检测的方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fbc1595e2df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369002, encodeId=b3e813690027b, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Oncogene：Kras突变能够诱导的CD24表达上调能够增强前列腺癌的多能性和骨转移, objectType=article, longId=156369, objectId=cc76156369d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc76156369d4, replyNumber=0, likeNumber=73, createdTime=2018-12-23, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc76156369d4, moduleTitle=Oncogene：Kras突变能够诱导的CD24表达上调能够增强前列腺癌的多能性和骨转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc76156369d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369001, encodeId=0cb0136900169, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Blood：Sos1缺陷可缓解致瘤性Kras[G12D]所诱导的骨髓增生性肿瘤, objectType=article, longId=152683, objectId=d3ff1526838c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3ff1526838c, replyNumber=0, likeNumber=98, createdTime=2018-11-04, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3ff1526838c, moduleTitle=Blood：Sos1缺陷可缓解致瘤性Kras[G12D]所诱导的骨髓增生性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3ff1526838c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369000, encodeId=0e2d1369000c7, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=CLIN CHEM：多重检测胰腺导管腺癌患者游离DNA 中KRAS突变的预后意义, objectType=article, longId=134277, objectId=24ab1342e7a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24ab1342e7a2, replyNumber=0, likeNumber=71, createdTime=2018-04-06, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24ab1342e7a2, moduleTitle=CLIN CHEM：多重检测胰腺导管腺癌患者游离DNA 中KRAS突变的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24ab1342e7a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368999, encodeId=acee13689993d, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=EUR J Cancer：帕尼单抗联合顺铂/吉西他滨治疗KRAS野生型胆管癌, objectType=article, longId=131020, objectId=199e13102034, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=199e13102034, replyNumber=0, likeNumber=64, createdTime=2018-03-02, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=199e13102034, moduleTitle=EUR J Cancer：帕尼单抗联合顺铂/吉西他滨治疗KRAS野生型胆管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=199e13102034)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368998, encodeId=5113136899826, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Oncologist：突变KRAS循环肿瘤DNA——胰腺癌监测的准确工具, objectType=article, longId=128344, objectId=7ece12834425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ece12834425, replyNumber=0, likeNumber=0, createdTime=2018-02-01, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ece12834425, moduleTitle=Oncologist：突变KRAS循环肿瘤DNA——胰腺癌监测的准确工具, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ece12834425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368997, encodeId=9362136899e32, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Clin Chem：循环肿瘤细胞中AR-V7, AR-FL, PSA和KRAS位点点突变的原位检测和定量, objectType=article, longId=126535, objectId=73a5126535f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73a5126535f2, replyNumber=0, likeNumber=58, createdTime=2018-01-16, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73a5126535f2, moduleTitle=Clin Chem：循环肿瘤细胞中AR-V7, AR-FL, PSA和KRAS位点点突变的原位检测和定量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73a5126535f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368996, encodeId=96231368996e7, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=NEJM：KRAS激活突变导致脑动静脉畸形, objectType=article, longId=125505, objectId=b0ea125505f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0ea125505f2, replyNumber=0, likeNumber=85, createdTime=2018-01-06, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0ea125505f2, moduleTitle=NEJM：KRAS激活突变导致脑动静脉畸形, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0ea125505f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368995, encodeId=8f611368995b0, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=EUR J Cancer：放疗联合卡培他滨和索拉非尼治疗晚期KRAS突变的直肠癌：I / II期临床试验（SAKK 41/08）, objectType=article, longId=124481, objectId=c81c12448125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c81c12448125, replyNumber=0, likeNumber=71, createdTime=2017-12-26, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c81c12448125, moduleTitle=EUR J Cancer：放疗联合卡培他滨和索拉非尼治疗晚期KRAS突变的直肠癌：I / II期临床试验（SAKK 41/08）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c81c12448125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368994, encodeId=a2cd13689942b, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Lancet Gastroen Hepatol：BRAF， PIK3CA， KRAS以及 NRAS野生型晚期或转移性结直肠癌患者多信号通路联合治疗研究, objectType=article, longId=123846, objectId=166d123846a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=166d123846a2, replyNumber=0, likeNumber=67, createdTime=2017-12-20, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=166d123846a2, moduleTitle=Lancet Gastroen Hepatol：BRAF， PIK3CA， KRAS以及 NRAS野生型晚期或转移性结直肠癌患者多信号通路联合治疗研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=166d123846a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368993, encodeId=45091368993fa, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=CLIN CANCER RES：WEE1和mTOR协同抑制治疗KRAS突变肺癌, objectType=article, longId=121369, objectId=ea411213694d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea411213694d, replyNumber=0, likeNumber=88, createdTime=2017-11-27, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea411213694d, moduleTitle=CLIN CANCER RES：WEE1和mTOR协同抑制治疗KRAS突变肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea411213694d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368992, encodeId=2a231368992a8, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=ANN SURG：解剖性切除可以改善KRAS突变结直肠癌肝转移患者无病生存, objectType=article, longId=114633, objectId=757411463395, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=757411463395, replyNumber=0, likeNumber=91, createdTime=2017-09-30, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=757411463395, moduleTitle=ANN SURG：解剖性切除可以改善KRAS突变结直肠癌肝转移患者无病生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=757411463395)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368991, encodeId=6d3c136899114, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Sci Rep：不同类型胰腺癌细胞中KRAS突变的异质性, objectType=article, longId=110587, objectId=940911058e28, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=940911058e28, replyNumber=0, likeNumber=58, createdTime=2017-08-24, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=940911058e28, moduleTitle=Sci Rep：不同类型胰腺癌细胞中KRAS突变的异质性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=940911058e28)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368990, encodeId=afef13689907d, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=JAMA：KRAS野生型晚期或转移性结直肠癌：西妥昔单抗 vs 贝伐珠单抗, objectType=article, longId=108199, objectId=19871081992f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19871081992f, replyNumber=0, likeNumber=73, createdTime=2017-08-11, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19871081992f, moduleTitle=JAMA：KRAS野生型晚期或转移性结直肠癌：西妥昔单抗 vs 贝伐珠单抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19871081992f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368989, encodeId=028013689899f, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=JCO:NSAID可显着改善KRAS野生型患者的生存, objectType=article, longId=104813, objectId=403e10481310, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=403e10481310, replyNumber=0, likeNumber=57, createdTime=2017-07-08, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=403e10481310, moduleTitle=JCO:NSAID可显着改善KRAS野生型患者的生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=403e10481310)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368988, encodeId=0a96136898817, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应, objectType=article, longId=104354, objectId=cb2b10435459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2b10435459, replyNumber=0, likeNumber=78, createdTime=2017-07-04, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2b10435459, moduleTitle=CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2b10435459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368987, encodeId=02ba136898ee7, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=JAMA:一线化疗联合Cetuximab 或 Bevacizumab对KRAS野生型晚期或转移性结肠直肠癌患者生存的影响, objectType=article, longId=102999, objectId=5d36102999e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d36102999e4, replyNumber=0, likeNumber=71, createdTime=2017-06-24, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d36102999e4, moduleTitle=JAMA:一线化疗联合Cetuximab 或 Bevacizumab对KRAS野生型晚期或转移性结肠直肠癌患者生存的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d36102999e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368986, encodeId=b00f136898680, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=JAMA Oncology：头颈部鳞状细胞癌KRAS变异与西妥昔单抗反应, objectType=article, longId=98232, objectId=5bb1982322d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bb1982322d, replyNumber=0, likeNumber=90, createdTime=2017-05-10, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bb1982322d, moduleTitle=JAMA Oncology：头颈部鳞状细胞癌KRAS变异与西妥昔单抗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bb1982322d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368985, encodeId=ebb81368985f0, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Br J Cancer：野生型KRAS或RAS转移性结直肠癌：帕尼单抗联合更佳支持治疗, objectType=article, longId=80610, objectId=9e8d8061024, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8d8061024, replyNumber=0, likeNumber=74, createdTime=2016-10-22, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8d8061024, moduleTitle=Br J Cancer：野生型KRAS或RAS转移性结直肠癌：帕尼单抗联合更佳支持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e8d8061024)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368984, encodeId=b8821368984b6, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Cell Rep:科学家找到靶向KRAS途径治疗肺癌的新靶点, objectType=article, longId=74343, objectId=81c2e4343a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81c2e4343a9, replyNumber=0, likeNumber=61, createdTime=2016-08-04, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81c2e4343a9, moduleTitle=Cell Rep:科学家找到靶向KRAS途径治疗肺癌的新靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81c2e4343a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

KRAS

2020-05-29

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

ARCH PATHOL LAB MED：肺癌，结直肠癌和胰腺癌组织和血浆中KRAS突变检测的方法

2019-02-08

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Oncogene：Kras突变能够诱导的CD24表达上调能够增强前列腺癌的多能性和骨转移

2018-12-23

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Blood：Sos1缺陷可缓解致瘤性Kras[G12D]所诱导的骨髓增生性肿瘤

2018-11-04

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

CLIN CHEM：多重检测胰腺导管腺癌患者游离DNA 中KRAS突变的预后意义

2018-04-06

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

EUR J Cancer：帕尼单抗联合顺铂/吉西他滨治疗KRAS野生型胆管癌

2018-03-02

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Oncologist：突变KRAS循环肿瘤DNA——胰腺癌监测的准确工具

2018-02-01

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Clin Chem：循环肿瘤细胞中AR-V7, AR-FL, PSA和KRAS位点点突变的原位检测和定量

2018-01-16

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

NEJM：KRAS激活突变导致脑动静脉畸形

2018-01-06

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

EUR J Cancer：放疗联合卡培他滨和索拉非尼治疗晚期KRAS突变的直肠癌：I / II期临床试验（SAKK 41/08）

2017-12-26

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Lancet Gastroen Hepatol：BRAF， PIK3CA， KRAS以及 NRAS野生型晚期或转移性结直肠癌患者多信号通路联合治疗研究

2017-12-20

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

CLIN CANCER RES：WEE1和mTOR协同抑制治疗KRAS突变肺癌

2017-11-27

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

ANN SURG：解剖性切除可以改善KRAS突变结直肠癌肝转移患者无病生存

2017-09-30

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Sci Rep：不同类型胰腺癌细胞中KRAS突变的异质性

2017-08-24

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

JAMA：KRAS野生型晚期或转移性结直肠癌：西妥昔单抗 vs 贝伐珠单抗

2017-08-11

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

JCO:NSAID可显着改善KRAS野生型患者的生存

2017-07-08

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应

2017-07-04

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

JAMA:一线化疗联合Cetuximab 或 Bevacizumab对KRAS野生型晚期或转移性结肠直肠癌患者生存的影响

2017-06-24

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

JAMA Oncology：头颈部鳞状细胞癌KRAS变异与西妥昔单抗反应

2017-05-10

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Br J Cancer：野生型KRAS或RAS转移性结直肠癌：帕尼单抗联合更佳支持治疗

2016-10-22

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Cell Rep:科学家找到靶向KRAS途径治疗肺癌的新靶点

2016-08-04

科室
- - 订阅+
  - 更多科室
工具
服务